Make sure to join DNI president @drdeanelbe.bsky.social
and senior dietitian Dr. Mary Litchford for a live DNI site demo at the Nutrition Informatics DPG Virtual Tech Fair Tuesday May 13th at 1000h Central Time.

Pleased to present to Dr Kevin Ansah and the team at Fairmont Pediatrics this morning on Pharmacogenomics & Youth Mental Health

XSyntis Bio SYNT-101 pill appears to mimic gastric bypass effects without surgery. It creates a temporary coating in the upper intestine, activating satiety hormones for sustainable weight loss. Early animal and human trials showed promising results. www.drugnutritioninteractions.com#/news/news-d...

Mark your calendars and join DNI president Dr. Dean Elbe and Senior Dietitian Dr. Mary Litchford at the 7th Nutrition Informatics DPG Virtual Tech Fair, Tues May 13th at 1000h Central. Dean and Mary discuss how the DNI site can support dietitian's practice and offer a live site demo.

>24 month use of inhaled corticosteroids in COPD ▲risk of diabetes and osteoporosis/fractures, pneumonia & cataracts. Strategies to ▼ risks include dietary calcium & vitamin D for bone health & balanced macronutrient intake to regulate blood glucose
www.drugnutritioninteractions.com#/news/news-d...

Recent updates from CDC & NIH highlight the need for individual advice on infant feeding for HIV+ mothers, including formula, donor milk, or breastfeeding. Stopping breastfeeding is recommended until viral load is undetectable. www.drugnutritioninteractions.com#/news/news-d...

Having lots of great conversations with dietetic internship coordinators at the #NDEP meeting in Memphis. Come visit the DNI booth for free demos and discounted annual subscriptions for dietetic students and interns

The adverse effects/lab changes with the little skull and crossbones icons in this graphic are signs of vitamin A toxicity

Signs of vitamin A toxicity include all the entries marked with the little skull and crossbones icon

Check out the interview by Heather Davis MS, RDN, LDN with @dninteractions.bsky.social President Dr. Dean Elbe in the March 2025 issue of Today's Dietitian
todaysdietitian.com/issues/2025/...

Promising results for orforglipron (oral non-peptide GLP-1 agonist; may be approved by 2026): 42% ▼hs-CRP, ▼IL-6 at higher doses, ▼ weight up to 15%, waist circumference by 13.6 cm. Oral admin more convenient c/w injection, better adherence, ▼ cost.
www.drugnutritioninteractions.com#/news/news-d...

Israeli researchers identified a gene responsible for furanocoumarin production in grapefruit. Editing this gene with CRISPR technology could produce a variety of grapefruit that doesn't interfere with medications. www.drugnutritioninteractions.com#/news/news-d...

GLP-1s show weight loss but also a concerning loss of muscle mass. Weight loss drugs in development target proteins like myostatin & activin to help preserve muscle mass while ▼ excess fat. Enobosarm ▼ muscle loss 71% with semaglutide in early trials www.drugnutritioninteractions.com#/news/news-d...